Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

EU approves Sivantos and Widex $8.3 billion hearing aid merger

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

February 21, 2019

Sivantos, headquartered in Singapore, is operating hearing devices by using data obtained from an electromyography of a user's auricular muscle.
Sivantos and Widex have won EU approval for their $8.3 billion hearing aid merger.


Relevant Patent Documents

Application US20190052978  

Article Source Link

Reuters


View Patent Forecast®

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.

AI Biotech/Diagnostics: Other Innovation   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.



301